Evangelos Liberopoulos

Author

Also Known As

E LIBEROPOULOS, E Liberopoulos, E N Liberopoulos, E. Liberopoulos, E. N. Liberopoulos, E.N Liberopoulos, E.N. Liberopoulos, EN Liberopoulos, EVANGELOS LIBEROPOULOS, Evagellos Liberopoulos

549

Publications

10.5K

Citations

H-Index

118

Concepts

All Affiliations

University of Ioannina National and Kapodistrian University of Athens Aristotle University of Thessaloniki University College London The Royal Free Hospital

About

Evangelos Liberopoulos is an author at University of Ioannina specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	51	2.5K
2	Public Health	19	26	1.4K
3	Health Sciences	14	16	480
4	Biochemistry	3	3	111
5	Biostatistics	1	1	21

Evangelos Liberopoulos

133

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study Vasilios G. Athyros, Dimitri P. Mikhailidis, Triantafyllos Didangelos, Current Medical Research and Opinion	2006	245
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens, Atherosclerosis Family MedicineLipid DisorderPrimary CareCardiovascular EpidemiologyHealth Policy	2018	228
&#x201C;European Panel on Low Density Lipoprotein (LDL) Subclasses&#x201D;: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Current Vascular Pharmacology HyperlipidemiaEuropean PanelObesityMetabolic SyndromeBody Composition	2011	197
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study Vasilios G. Athyros, D. P. Mikhailidis, Evangelos Liberopoulos, Nephrology Dialysis Transplantation	2006	184
Familial hypercholesterolaemia: A global call to arms Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, Atherosclerosis Metabolic SyndromeFamily MedicineLipid DisorderCardiovascular DiseaseHyperlipidemia	2015	178
Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort Vasilios G. Athyros, Evangelos Liberopoulos, Dimitri P. Mikhailidis, Angiology	2007	153
&#x201C;European Panel On Low Density Lipoprotein (LDL) Subclasses&#x201D;: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Current Vascular Pharmacology Ldl SubclassesFull TextLanguage DocumentationCardiovascular EpidemiologyCardiovascular Disease	2011	113
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration Antonio J. Vallejo‐Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai, Atherosclerosis Supplements	2016	112
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab Emil Hagström, Philippe Gabríel Steg, Michael Szarek, Circulation	2022	112

Page 1